---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-361079"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2026-08-21T20:05:14+00:00"
generated_at: "2026-08-21T20:06:15.020736+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aptevo annual meeting: both director nominees elected, all four proposals approved

## Summary
- Zs. Harsanyi re-elected director: 216,997 for, 17,454 withheld; Barbara Lopez Kunz: 211,050 for, 23,401 withheld.
- Ratification of Baker Tilly US LLP as 2026 auditor: 606,661 for, 28,847 against, 1,370 abstain.
- Advisory vote on 2025 executive compensation approved: 165,615 for, 24,031 against, 44,805 abstain.
- Fourth Amended and Restated 2018 Stock Incentive Plan approved: 166,484 for, 64,248 against, 3,719 abstain.

## SEC filing metadata
- accession: 0001193125-26-361079
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2026-08-21T20:05:14+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000119312526361079/0001193125-26-361079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000119312526361079/apvo-20260821.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-361079
- JSON: https://secwatch.observer/filing/0001193125-26-361079.json
- Plain text: https://secwatch.observer/filing/0001193125-26-361079.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.